We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+14.86%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$20.4B
AUM Growth
+$1.83B
Cap. Flow
-$269M
Cap. Flow %
-1.32%
Top 10 Hldgs %
26.04%
Holding
474
New
71
Increased
102
Reduced
215
Closed
54

Top Buys

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$235M
2
CFLT
Confluent
CFLT
+$128M
3
HNST icon
The Honest Company
HNST
+$90.9M
4
DKS icon
Dick's Sporting Goods
DKS
+$87.3M
5
PATH icon
UiPath
PATH
+$34.9M

Top Sells

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$100M
2
TSLA icon
Tesla
TSLA
+$75.7M
3
ROKU icon
Roku
ROKU
+$56.8M
4
CVNA icon
Carvana
CVNA
+$52.8M
5
OSH
Oak Street Health, Inc.
OSH
+$40.6M

Sector Composition

Rank Sector Weight
1 Technology 30.52%
2 Healthcare 20.52%
3 Consumer Discretionary 17.63%
4 Communication Services 12.09%
5 Miscellaneous 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
301
Biogen
BIIB
$31.9B
$967K ﹤0.01%
2,794
-3,634
-57% -$1.1M
ARLO icon
302
Arlo Technologies
ARLO
$1.45B
$954K ﹤0.01%
+140,918
New +$918K
SGTX
303
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$909K ﹤0.01%
6,515
-43,809
-87% -$7.7M
CCC
304
CCC Intelligent Solutions
CCC
$3.89B
$902K ﹤0.01%
90,588
+1,358
+2% +$13.7K
BSX icon
305
Boston Scientific
BSX
$63.6B
$883K ﹤0.01%
20,647
-101
-0.5% -$4.25K
SLGC
306
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$882K ﹤0.01%
+71,938
New +$882K
SMAR
307
DELISTED
Smartsheet Inc.
SMAR
$845K ﹤0.01%
11,683
LNW
308
DELISTED
Light & Wonder
LNW
$840K ﹤0.01%
10,846
-40
-0.4% -$2.46K
TSHA icon
309
Taysha Gene Therapies
TSHA
$1.65B
$798K ﹤0.01%
37,640
-184
-0.5% -$4.24K
GH icon
310
Guardant Health
GH
$23.6B
$764K ﹤0.01%
6,149
-14,968
-71% -$2.01M
LUV icon
311
Southwest Airlines
LUV
$19.2B
$742K ﹤0.01%
13,979
-61
-0.4% -$3.66K
PACB icon
312
Pacific Biosciences
PACB
$417M
$708K ﹤0.01%
20,237
-69
-0.3% -$2.01K
OLO
313
DELISTED
Olo Inc
OLO
$630K ﹤0.01%
16,845
-1,678
-9% -$53.3K
SRPT icon
314
Sarepta Therapeutics
SRPT
$2.19B
$626K ﹤0.01%
8,047
-2
-0% -$152
OTLY
315
Oatly Group
OTLY
$401M
$619K ﹤0.01%
+1,265
New +$629K
YOU icon
316
Clear Secure
YOU
$4.28B
$611K ﹤0.01%
+15,264
New +$611K
ATEX icon
317
Anterix
ATEX
$1.49B
$560K ﹤0.01%
9,343
+2,913
+45% +$146K
ZG icon
318
Zillow
ZG
$7.46B
$511K ﹤0.01%
4,169
+77
+2% +$9.51K
VINP icon
319
Vinci Compass Investments Ltd
VINP
$611M
$475K ﹤0.01%
32,786
+2,025
+7% +$26.5K
PCT icon
320
PureCycle Technologies
PCT
$1.12B
$423K ﹤0.01%
17,872
+5,502
+44% +$118K
AGC
321
DELISTED
Altimeter Growth Corp
AGC
$390K ﹤0.01%
33,315
KBH icon
322
KB Home
KBH
$3.04B
$378K ﹤0.01%
9,272
+118
+1% +$5.44K
RNAM
323
DELISTED
Avidity Biosciences
RNAM
$360K ﹤0.01%
14,570
+1,414
+11% +$32.9K
TASK icon
324
TaskUs
TASK
$758M
$342K ﹤0.01%
+10,000
New +$316K
KNSL icon
325
Kinsale Capital Group
KNSL
$8.41B
$340K ﹤0.01%
2,062
+488
+31% +$80.5K

Similar funds

Gilder Gagnon Howe & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Gilder Gagnon Howe & Co held 474 positions worth $20.4B, up 9.8% from $18.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2021 filing shows 71 new, 102 increased, 215 reduced and 54 closed positions. Its largest new stake was Procore: 2,675,759 shares worth $254M. The largest sale was Autodesk, an estimated $100M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q2 2021 buy was Procore: 2,675,759 shares worth $254M.
  • Gilder Gagnon Howe & Co added most to Lindblad Expeditions in Q2 2021, an estimated $18.4M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2021 reduction was Autodesk, cutting an estimated $100M.
  • Gilder Gagnon Howe & Co fully exited SoFi Technologies in Q2 2021, selling an estimated $39.9M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $20.4B portfolio in Q2 2021.
  • Gilder Gagnon Howe & Co opened 71 new positions and closed 54 in Q2 2021.
  • Gilder Gagnon Howe & Co's portfolio value rose 9.8% quarter-over-quarter to $20.4B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2021, filed 16 Aug 2021.